Bacteroides thetaiotaomicron

Last updated

Contents

Bacteroides thetaiotaomicron
Bacteroides thetaiotaomicron.png
Scientific classification OOjs UI icon edit-ltr.svg
Domain: Bacteria
Phylum: Bacteroidota
Class: Bacteroidia
Order: Bacteroidales
Family: Bacteroidaceae
Genus: Bacteroides
Species:
B. thetaiotaomicron
Binomial name
Bacteroides thetaiotaomicron
(Distaso 1912) Castellani and Chalmers 1919

Bacteroides thetaiotaomicron is a gram-negative, rod shaped obligate anaerobic bacterium that is a prominent member of the normal gut microbiome in the distal intestines. Its proteome, consisting of 4,779 members, includes a system for obtaining and breaking down dietary polysaccharides that would otherwise be difficult to digest. [1] B. thetaiotaomicron is also an opportunistic pathogen, meaning it may become virulent in immunocompromised individuals. It is often used in research as a model organism for functional studies of the human microbiota. [2]

History and taxonomy

Bacteroides thetaiotaomicron was first described in 1912 under the name Bacillus thetaiotaomicron and moved to the genus Bacteroides in 1919. [3] The B. thetaiotaomicron type strain VPI-5482 was originally isolated from a healthy adult's human feces. [1] The specific name derives from the Greek letters theta, iota, and omicron; the List of Prokaryotic names with Standing in Nomenclature indicates this as "relating to the morphology of vacuolated forms". [3] The Bacteroidota bacterial phylum, distinguished by its unique motility, is present in a wide range of ecosystems, habitats, lifestyles, and physiological conditions. [4] The name is used as an example of an "arbitrary" species name in the International Code of Nomenclature of Prokaryotes. [5] [6]

Genome

The genome of B. thetaiotaomicron was sequenced in 2003. It is one circular chromosome of double stranded DNA. It is 6.26 megabases in length, but has a relatively small number of distinct genes, due to genes coding for proteins that are unusually large compared to other prokaryotes. [1] This genomic feature is shared with another member of the genus, Bacteroides fragilis . [7] The genome contains genes associated with breaking down polysaccharides, including glycoside hydrolases and starch binding proteins. [1] [7] These genes along with ECF-type sigma factors allow B. thetaiotaomicron to correlate the availability of nutrients with expression of the particular genes. [1] The genome also contains many genes encoding proteins involved in sensing and responding to the extracellular environment, such as sigma factors and two-component systems. [1] [8] [9] The colocalization of the gene encoding digestive enzymes with extracytoplasmic function sigma factors and signal transduction systems creates a mechanism that regulates gene expression based on the availability of nutrients in the environment. [1] The B. thetaiotaomicron genome encodes a large number of small non-coding RNAs which also play a key role in regulatory processes, though few have been characterized to date. [2] B. thetaiotaomicron has several different types of mobile genetic elements, including a 33 kilobase plasmid, 63 transposases, and four homologs of the conjugative transposon CTnDOT. CTnDOT encodes the resistance to the antibiotics erythromycin and tetracycline, and is horizontally transferred between Bacteroides species as well as other gut microbiota. [1]

Metabolism

Bacteroides thetaiotaomicron is capable of metabolizing a very diverse range of otherwise indigestible polysaccharides, like amylose, amylopectin, and pullulan. [8] Its complement of enzymes used for hydrolysis of glycosidic bonds is among the largest known in prokaryotes, and is even thought to be capable of hydrolyzing nearly all glycosidic bonds in biological polysaccharides. As the major organism of the human gut flora to break down plant polysaccharides it can use both dietary carbohydrates, as well as those sourced from the host, depending on nutrient availability. [10] Complex plant polysaccharides, unlike simple monosaccharides and disaccharides that are digested and absorbed in the small intestines, are left to be used as a food source in the colon. [11] B. thetaiotaomicron is able to dominate the many other gut bacteria living within the human colonic environment using its superior ability to acquire sufficient nutrients. [11] This is possible due to the combined effects of an increased amount of glycosyl hydrolases, that degrade enzymes, membrane binding proteins, and sugar-specific transporters. [11] There are 172 glycosylhydrolases produced by B. thetaiotaomicron which is greater than any other sequenced bacterium, contributing to enzymes that contribute products of hydrolysis to the host. [11] All Bacteriodes employ polysaccharide-utilization loci (PULs) whose gene clusters encode systems that target and degrade carbohydrates. [12] A part of these systems are carbohydrate-active enzymes (CAZymes) that can very efficiently degrade complex carbohydrates found in the diet. There have been three different PULs identified that use RG-II, a dietary carbohydrate with the most structural complexity, as a substrate The RG-II degradome contains 23 enzymes that target sequential glycosidic linkage in the RG-II, leading to its disassembly. [12]

B. thetaiotaomicron is aerotolerant and can survive, but not grow, when exposed to oxygen. Oxygen has limited access in eukaryotic host environments, like the human intestines. Generation of reactive oxygen species (ROS) such as hydrogen peroxide may occur, threatening the flora by attacking iron cofactors enzymes widely used in metabolism. [13] To drive the oxygen concentration to lower levels, B. thetaiotaomicron expresses a number of proteins that scavenge ROS such as hydrogen peroxide when exposed to air. [13]

Role in the human microbiome

Members of the genus Bacteroides accounts for about a quarter of the microbial population in an adult human's intestine. In a long-term study of Bacteroides species in clinical samples, B. thetaiotaomicron was the second most common species isolated, behind Bacteroides fragilis . [13] It is crucial to humans as it is able to digest plant materials that enzymes within the gut cannot. [1]

B. thetaiotaomicron is considered commensal, a type of symbiosis, meaning it provides the host with key benefits like digestion. [1] [7] B. thetaiotaomicron has far more glycosyl hydrolases, in which 61% are located in the outer membrane or extracellular matrix, suggesting that the digestive capabilities serve the bacteria's host more than anything. [8] The glycosyl hydrolases express 23 specific enzymatic functions that supply the host or even other microbes in the gut flora with the breakdown products of hydrolysis. [11] The polysaccharides that are digested by B. thetaiotaomicron are converted into monosaccharides which can then be absorbed by human cells for metabolism. [11]

Previous studies show that B. thetaiotaomicron stimulates angiogenesis, which is the formation of new blood vessels, during intestinal development following birth. These studies used germ-free mice in order to control the microbiota and inoculated the mice with a specific bacteria, B. thetaiotaomicron. Angiogenesis further benefits the host by increasing the human's ability to absorb the nutrients that the microbe assists in produce. [1]

B. thetaiotaomicron dominates the intestinal microbiome and also aids in another postnatal development of the gut with the formation of the mucosal barrier in the intestine, which plays a major role in maintaining host-microbiota homeostasis. [14] [15] The mucosal barrier, located between the intestinal epithelium and microbiota, is semipermeable, allowing the uptake of essential nutrients while restricting the passage of pathogenic molecules. [14] [16] Nearly 90% of the bacteria within the gut microbiota, colonizing the gastrointestinal tract (GIT), belongs to the Bacteroidetes or Firmicutes phyla. [14] B. thetaiotaomicron's ability to grow on host-derived polysaccharides in mucus is a major contributor to its persistence in the GIT. [14]  

Role in immune response

B. thetaiotaomicron is a prominent member of the human gut microbiota, and its role in the immune response is complex. The interaction between B. thetaiotaomicron and the immune system contributes to the maintenance of gut homeostasis and the development of an immune system. The anti-inflammatory and immunomodulatory characteristics of extracellular vesicles generated by the prevalent human gut bacteria B. thetaiotaomicron are evident, along with the identification of the molecular mechanisms governing their interaction with innate immune cells. [17] B.thetaiotaomicron has been associated with other commensal bacteria and the induction of regulatory T cells which are essential for maintaining immune tolerance and preventing excessive inflammatory response. [18] [19]

The outer membrane vesicles (OMVs) not only aid in protecting B. thetaiotaomicron from degradation, but also play a major role in promoting regulatory dendritic cell responses. OMVs of B. thetaiotaomicron in a healthy gut stimulate colonic dendritic cells (DC) to express IL-10. T-cells are stimulated by IL-10 and is expressed via the innate immune system through macrophages and DC. B. thetaiotaomicron OMVs in individuals with ulcerative colitis (UC) and Crohn's disease (CD) are unable to stimulate IL-10 expression, resulting in a loss of regulatory DC. In these diseases, B. thetaiotaomicron OMVs also cause a significantly lower amount of DC to be expressed. These results were also observed in patients with the inactive diseases, signifying that the defects in immune response are intrinsic in inflammatory bowel disease (IBD). [20] [ better source needed ]

Pathology

B. thetaiotaomicron is also an opportunistic pathogen and can infect tissues exposed to gut flora. [13] While contained in the gut, B. thetaiotaomicron generally maintains a beneficial relationship with its host. However, the bacteria can cause serious pathology when it is present in an inappropriate environment. Bacteria can escape the gut as a result of a rupture of the gastrointestinal tract. This can lead to diseases like bacteremia, which is the presence of bacteria in the bloodstream. It can also lead to abscess formation, which occurs when an area of tissue is infected and the body's immune system sends white blood cells to try to fight and contain it. [7]

Its polysaccharide-metabolizing abilities make it a food source for other components of the gut microbiome. For example, while B. thetaiotaomicron expresses sialidase enzymes, it cannot catabolize sialic acid; as a result its presence increases the free sialic acid available for other organisms in the gut to use as an energy source. These interactions can contribute to the growth of pathogenic bacteria such as Clostridium difficile , which uses sialic acid as a carbon source. [21] Similar interactions can cause B. thetaiotaomicron to exacerbate pathogenic E. coli infection. [22] These strategies allow B. thetaiotaomicron to further thrive in the competitive environment of the human intestine.

Related Research Articles

<span class="mw-page-title-main">Large intestine</span> Last part of the digestive system in vertebrates

The large intestine, also known as the large bowel, is the last part of the gastrointestinal tract and of the digestive system in tetrapods. Water is absorbed here and the remaining waste material is stored in the rectum as feces before being removed by defecation. The colon is the longest portion of the large intestine, and the terms are often used interchangeably but most sources define the large intestine as the combination of the cecum, colon, rectum, and anal canal. Some other sources exclude the anal canal.

<span class="mw-page-title-main">Human microbiome</span> Microorganisms in or on human skin and biofluids

The human microbiome is the aggregate of all microbiota that reside on or within human tissues and biofluids along with the corresponding anatomical sites in which they reside, including the gastrointestinal tract, skin, mammary glands, seminal fluid, uterus, ovarian follicles, lung, saliva, oral mucosa, conjunctiva, and the biliary tract. Types of human microbiota include bacteria, archaea, fungi, protists, and viruses. Though micro-animals can also live on the human body, they are typically excluded from this definition. In the context of genomics, the term human microbiome is sometimes used to refer to the collective genomes of resident microorganisms; however, the term human metagenome has the same meaning.

<span class="mw-page-title-main">Gut microbiota</span> Community of microorganisms in the gut

Gut microbiota, gut microbiome, or gut flora are the microorganisms, including bacteria, archaea, fungi, and viruses, that live in the digestive tracts of animals. The gastrointestinal metagenome is the aggregate of all the genomes of the gut microbiota. The gut is the main location of the human microbiome. The gut microbiota has broad impacts, including effects on colonization, resistance to pathogens, maintaining the intestinal epithelium, metabolizing dietary and pharmaceutical compounds, controlling immune function, and even behavior through the gut–brain axis.

<i>Bacteroides</i> Genus of bacteria

Bacteroides is a genus of Gram-negative, obligate anaerobic bacteria. Bacteroides species are non endospore-forming bacilli, and may be either motile or nonmotile, depending on the species. The DNA base composition is 40–48% GC. Unusual in bacterial organisms, Bacteroides membranes contain sphingolipids. They also contain meso-diaminopimelic acid in their peptidoglycan layer.

<i>Bacteroides fragilis</i> Species of bacterium

Bacteroides fragilis is an anaerobic, Gram-negative, pleomorphic to rod-shaped bacterium. It is part of the normal microbiota of the human colon and is generally commensal, but can cause infection if displaced into the bloodstream or surrounding tissue following surgery, disease, or trauma.

Dysbiosis is characterized by a disruption to the microbiome resulting in an imbalance in the microbiota, changes in their functional composition and metabolic activities, or a shift in their local distribution. For example, a part of the human microbiota such as the skin flora, gut flora, or vaginal flora, can become deranged, with normally dominating species underrepresented and normally outcompeted or contained species increasing to fill the void. Similar to the human gut microbiome, diverse microbes colonize the plant rhizosphere, and dysbiosis in the rhizosphere, can negatively impact plant health. Dysbiosis is most commonly reported as a condition in the gastrointestinal tract or plant rhizosphere.

<span class="mw-page-title-main">Oral microbiology</span>

Oral microbiology is the study of the microorganisms (microbiota) of the oral cavity and their interactions between oral microorganisms or with the host. The environment present in the human mouth is suited to the growth of characteristic microorganisms found there. It provides a source of water and nutrients, as well as a moderate temperature. Resident microbes of the mouth adhere to the teeth and gums to resist mechanical flushing from the mouth to stomach where acid-sensitive microbes are destroyed by hydrochloric acid.

Methanobrevibacter smithii is the predominant archaeon in the microbiota of the human gut. M. smithii has a coccobacillus shape. It plays an important role in the efficient digestion of polysaccharides by consuming the end products of bacterial fermentation. Methanobrevibacter smithii is a single-celled microorganism from the Archaea domain. M. smithii is a methanogen, and a hydrogenotroph that recycles the hydrogen by combining it with carbon dioxide to methane. The removal of hydrogen by M. smithii is thought to allow an increase in the extraction of energy from nutrients by shifting bacterial fermentation to more oxidized end products.

<span class="mw-page-title-main">Microbial symbiosis and immunity</span>

Long-term close-knit interactions between symbiotic microbes and their host can alter host immune system responses to other microorganisms, including pathogens, and are required to maintain proper homeostasis. The immune system is a host defense system consisting of anatomical physical barriers as well as physiological and cellular responses, which protect the host against harmful microorganisms while limiting host responses to harmless symbionts. Humans are home to 1013 to 1014 bacteria, roughly equivalent to the number of human cells, and while these bacteria can be pathogenic to their host most of them are mutually beneficial to both the host and bacteria.

<span class="mw-page-title-main">Microbiota</span> Community of microorganisms

Microbiota are the range of microorganisms that may be commensal, mutualistic, or pathogenic found in and on all multicellular organisms, including plants. Microbiota include bacteria, archaea, protists, fungi, and viruses, and have been found to be crucial for immunologic, hormonal, and metabolic homeostasis of their host.

Faecalibacterium is a genus of bacteria. The genus contains several species including Faecalibacterium prausnitzii, Faecalibacterium butyricigenerans, Faecalibacterium longum, Faecalibacterium duncaniae, Faecalibacterium hattorii, and Faecalibacterium gallinarum. Its first known species, Faecalibacterium prausnitzii is gram-positive, mesophilic, rod-shaped, and anaerobic, and is one of the most abundant and important commensal bacteria of the human gut microbiota. It is non-spore forming and non-motile. These bacteria produce butyrate and other short-chain fatty acids through the fermentation of dietary fiber. The production of butyrate makes them an important member of the gut microbiota, fighting against inflammation.

Prevotella is a genus of Gram-negative bacteria.

Beta porphyranase is an enzyme responsible for the degradation of porphyran, which composes the cell wall of red algae. So far only five β-porphyranases have been identified: PorA and PorB are found in the marine bacteria Zobellia galactinovirans. A wild-type porphyranase activity has been found in Pseudoalteromonas atlantica. BpGH16B and BpGH86A have been found in the human gut bacterium, Bacteroides plebeius, of Japanese individuals.

Microbiota-accessible carbohydrates (MACs) are carbohydrates that are resistant to digestion by a host's metabolism, and are made available for gut microbes, as prebiotics, to ferment or metabolize into beneficial compounds, such as short chain fatty acids. The term, ‘‘microbiota-accessible carbohydrate’’ contributes to a conceptual framework for investigating and discussing the amount of metabolic activity that a specific food or carbohydrate can contribute to a host's microbiota.

Sarkis Mazmanian is an American medical microbiologist who has served as a professor at the California Institute of Technology since 2006. He is currently the Luis & Nelly Soux Professor of Microbiology in the Division of Biology and Biological Engineering, and a board member of Seed. Prior to this, Mazmanian was affiliated with Harvard Medical School and the University of Chicago. In 2012, Mazmanian was awarded a MacArthur Fellowship for his pioneering work on the human microbiome.

The microbiota are the sum of all symbiotic microorganisms living on or in an organism. The fruit fly Drosophila melanogaster is a model organism and known as one of the most investigated organisms worldwide. The microbiota in flies is less complex than that found in humans. It still has an influence on the fitness of the fly, and it affects different life-history characteristics such as lifespan, resistance against pathogens (immunity) and metabolic processes (digestion). Considering the comprehensive toolkit available for research in Drosophila, analysis of its microbiome could enhance our understanding of similar processes in other types of host-microbiota interactions, including those involving humans. Microbiota plays key roles in the intestinal immune and metabolic responses via their fermentation product, acetate.

<span class="mw-page-title-main">Pharmacomicrobiomics</span>

Pharmacomicrobiomics, proposed by Prof. Marco Candela for the ERC-2009-StG project call, and publicly coined for the first time in 2010 by Rizkallah et al., is defined as the effect of microbiome variations on drug disposition, action, and toxicity. Pharmacomicrobiomics is concerned with the interaction between xenobiotics, or foreign compounds, and the gut microbiome. It is estimated that over 100 trillion prokaryotes representing more than 1000 species reside in the gut. Within the gut, microbes help modulate developmental, immunological and nutrition host functions. The aggregate genome of microbes extends the metabolic capabilities of humans, allowing them to capture nutrients from diverse sources. Namely, through the secretion of enzymes that assist in the metabolism of chemicals foreign to the body, modification of liver and intestinal enzymes, and modulation of the expression of human metabolic genes, microbes can significantly impact the ingestion of xenobiotics.

<span class="mw-page-title-main">Human milk microbiome</span> Community of microorganisms in human milk

The human milk microbiota, also known as human milk probiotics (HMP), encompasses the microbiota–the community of microorganisms–present within the human mammary glands and breast milk. Contrary to the traditional belief that human breast milk is sterile, advancements in both microbial culture and culture-independent methods have confirmed that human milk harbors diverse communities of bacteria. These communities are distinct in composition from other microbial populations found within the human body which constitute the human microbiome.

Phocaeicola plebeius, formerly Bacteroides plebeius, is a microbe found in the human gut, most often found in Japan natives. It is able to digest porphyran, a polysacchide from Porphyra seaweed (nori) that humans cannot digest on their own. The porphyranase-encoding gene Bp1689 is believed to have been derived from the microbe Zobellia galactanivorans via horizontal gene transfer, as part of a gene cluster containing other carbohydrate-active enzymes.

<i>Phocaeicola vulgatus</i> Species of bacteria

Phocaeicola vulgatus,, is a mutualistic anaerobic Gram negative rod bacteria commonly found in the human gut microbiome and isolated from feces. P. vulgatus has medical relevance and has been notable in scientific research due to its production of fatty acids, potential use as a probiotic, and associations with protecting against and worsening some inflammatory diseases. Due to the difficulties in culturing anaerobic bacteria, P. vulgatus is still highly uncharacterised so efforts are being made to make use of multi-omic approaches to investigate the human gut microbiome more thoroughly in hopes to fully understand the role of this species in the development of and protection against diseases, as well as its potential uses in medicine and research. Generally, P. vulgatus is considered as a beneficial bacteria that contributes to digestion and a balanced microbiome, but it has been known to cause opportunistic infections and induce or worsen inflammatory responses. Due to its abundance in the microbiome, some researchers are investigating these species in hopes that it will be a suitable model organism for gut microbiome research, like Bacteroides thetaiotaomicron.

References

  1. 1 2 3 4 5 6 7 8 9 10 11 Xu J, Bjursell MK, Himrod J, Deng S, Carmichael LK, Chiang HC, et al. (March 2003). "A genomic view of the human-Bacteroides thetaiotaomicron symbiosis". Science. 299 (5615): 2074–2076. Bibcode:2003Sci...299.2074X. doi:10.1126/science.1080029. PMID   12663928. S2CID   34071235.
  2. 1 2 Ryan D, Jenniches L, Reichardt S, Barquist L, Westermann AJ (July 2020). "A high-resolution transcriptome map identifies small RNA regulation of metabolism in the gut microbe Bacteroides thetaiotaomicron". Nature Communications. 11 (1): 3557. Bibcode:2020NatCo..11.3557R. doi: 10.1038/s41467-020-17348-5 . PMC   7366714 . PMID   32678091.
  3. 1 2 "Bacteroides". List of Prokaryotic names with Standing in Nomenclature. Retrieved 20 May 2018.
  4. ↑ Hahnke RL, Meier-Kolthoff JP, García-López M, Mukherjee S, Huntemann M, Ivanova NN, et al. (2016-12-20). "Genome-Based Taxonomic Classification of Bacteroidetes". Frontiers in Microbiology. 7: 2003. doi: 10.3389/fmicb.2016.02003 . PMC   5167729 . PMID   28066339.
  5. ↑ Oren A, Vandamme P, Schink B (June 2016). "Notes on the use of Greek word roots in genus and species names of prokaryotes". International Journal of Systematic and Evolutionary Microbiology. 66 (6): 2129–2140. doi: 10.1099/ijsem.0.001063 . PMID   27055242.
  6. ↑ Trüper HG (April 1999). "How to name a prokaryote?: Etymological considerations, proposals and practical advice in prokaryote nomenclature". FEMS Microbiology Reviews. 23 (2): 231–249. doi: 10.1111/j.1574-6976.1999.tb00397.x .
  7. 1 2 3 4 Wexler HM (October 2007). "Bacteroides: the good, the bad, and the nitty-gritty". Clinical Microbiology Reviews. 20 (4): 593–621. doi:10.1128/CMR.00008-07. PMC   2176045 . PMID   17934076.
  8. 1 2 3 Xu J, Chiang HC, Bjursell MK, Gordon JI (January 2004). "Message from a human gut symbiont: sensitivity is a prerequisite for sharing". Trends in Microbiology. 12 (1): 21–28. doi:10.1016/j.tim.2003.11.007. PMID   14700548.
  9. ↑ Flint HJ, Bayer EA, Rincon MT, Lamed R, White BA (February 2008). "Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis". Nature Reviews. Microbiology. 6 (2): 121–131. doi:10.1038/nrmicro1817. PMID   18180751. S2CID   10400358.
  10. ↑ Sonnenburg JL, Xu J, Leip DD, Chen CH, Westover BP, Weatherford J, et al. (March 2005). "Glycan foraging in vivo by an intestine-adapted bacterial symbiont". Science. 307 (5717): 1955–1959. Bibcode:2005Sci...307.1955S. doi:10.1126/science.1109051. PMID   15790854. S2CID   13588903.
  11. 1 2 3 4 5 6 Comstock LE, Coyne MJ (October 2003). "Bacteroides thetaiotaomicron: a dynamic, niche-adapted human symbiont". BioEssays. 25 (10): 926–929. doi:10.1002/bies.10350. PMID   14505359.
  12. 1 2 Trovão F, Correia VG, Lourenço FM, Ribeiro DO, Carvalho AL, Palma AS, Pinheiro BA (2023-01-02). "The structure of a Bacteroides thetaiotaomicron carbohydrate-binding module provides new insight into the recognition of complex pectic polysaccharides by the human microbiome". Journal of Structural Biology. 7: 100084. doi: 10.1016/j.yjsbx.2022.100084 . PMC   9843283 . PMID   36660365.
  13. 1 2 3 4 Mishra S, Imlay JA (December 2013). "An anaerobic bacterium, Bacteroides thetaiotaomicron, uses a consortium of enzymes to scavenge hydrogen peroxide". Molecular Microbiology. 90 (6): 1356–1371. doi:10.1111/mmi.12438. PMC   3882148 . PMID   24164536.
  14. 1 2 3 4 Wrzosek L, Miquel S, Noordine ML, Bouet S, Joncquel Chevalier-Curt M, Robert V, et al. (May 2013). "Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent". BMC Biology. 11: 61. doi: 10.1186/1741-7007-11-61 . PMC   3673873 . PMID   23692866.
  15. ↑ Xu J, Gordon JI (September 2003). "Honor thy symbionts". Proceedings of the National Academy of Sciences of the United States of America. 100 (18): 10452–10459. doi: 10.1073/pnas.1734063100 . PMC   193582 . PMID   12923294.
  16. ↑ Vancamelbeke M, Vermeire S (September 2017). "The intestinal barrier: a fundamental role in health and disease". Expert Review of Gastroenterology & Hepatology. 11 (9): 821–834. doi:10.1080/17474124.2017.1343143. PMC   6104804 . PMID   28650209.
  17. ↑ Fonseca S, Carvalho AL, Miquel-Clopés A, Jones EJ, Juodeikis R, Stentz R, Carding SR (2022-11-10). "Extracellular vesicles produced by the human gut commensal bacterium Bacteroides thetaiotaomicron elicit anti-inflammatory responses from innate immune cells". Frontiers in Microbiology. 13: 1050271. doi: 10.3389/fmicb.2022.1050271 . PMC   9684339 . PMID   36439842.
  18. ↑ Wegorzewska MM, Glowacki RW, Hsieh SA, Donermeyer DL, Hickey CA, Horvath SC, et al. (February 2019). "Diet modulates colonic T cell responses by regulating the expression of a Bacteroides thetaiotaomicron antigen". Science Immunology. 4 (32). doi:10.1126/sciimmunol.aau9079. PMC   6550999 . PMID   30737355.
  19. ↑ Wu, Hsin-Jung; Wu, Eric (January 2012). "The role of gut microbiota in immune homeostasis and autoimmunity". Gut Microbes. 3 (1): 4–14. doi: 10.4161/gmic.19320 . ISSN   1949-0976. PMC   3337124 . PMID   22356853.
  20. ↑ Durant L, Stentz R, Noble A, Brooks J, Gicheva N, Reddi D, et al. (June 2020). "Bacteroides thetaiotaomicron-derived outer membrane vesicles promote regulatory dendritic cell responses in health but not in inflammatory bowel disease". Microbiome. 8 (1): 88. doi: 10.1186/s40168-020-00868-z . PMC   7282036 . PMID   32513301.
  21. ↑ Bäumler AJ, Sperandio V (July 2016). "Interactions between the microbiota and pathogenic bacteria in the gut". Nature. 535 (7610): 85–93. Bibcode:2016Natur.535...85B. doi:10.1038/nature18849. PMC   5114849 . PMID   27383983.
  22. ↑ Curtis MM, Hu Z, Klimko C, Narayanan S, Deberardinis R, Sperandio V (December 2014). "The gut commensal Bacteroides thetaiotaomicron exacerbates enteric infection through modification of the metabolic landscape". Cell Host & Microbe. 16 (6): 759–769. doi:10.1016/j.chom.2014.11.005. PMC   4269104 . PMID   25498343.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.